229 related articles for article (PubMed ID: 12766251)
1. A small molecule alpha4beta1/alpha4beta7 antagonist differentiates between the low-affinity states of alpha4beta1 and alpha4beta7: characterization of divalent cation dependence.
Egger LA; Cao J; McCallum C; Kidambi U; Van Riper G; McCauley E; Mumford RA; Lanza TJ; Lin LS; de Laszlo SE; Young DN; Yang G; Dean DC; Raab CE; Wallace MA; Jones AN; Hagmann WK; Schmidt JA; Pepinsky RB; Scott DM; Lee WC; Cornebise MA; Detmers PA
J Pharmacol Exp Ther; 2003 Sep; 306(3):903-13. PubMed ID: 12766251
[TBL] [Abstract][Full Text] [Related]
2. Effect of divalent cations on the affinity and selectivity of alpha4 integrins towards the integrin ligands vascular cell adhesion molecule-1 and mucosal addressin cell adhesion molecule-1: Ca2+ activation of integrin alpha4beta1 confers a distinct ligand specificity.
Day ES; Osborn L; Whitty A
Cell Commun Adhes; 2002; 9(4):205-19. PubMed ID: 12699089
[TBL] [Abstract][Full Text] [Related]
3. Evidence that ligand and metal ion binding to integrin alpha 4beta 1 are regulated through a coupled equilibrium.
Chen LL; Whitty A; Scott D; Lee WC; Cornebise M; Adams SP; Petter RC; Lobb RR; Pepinsky RB
J Biol Chem; 2001 Sep; 276(39):36520-9. PubMed ID: 11473127
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and analysis of a polyethelene glycol-modified (PEGylated) small molecule inhibitor of integrin {alpha}4{beta}1 with improved pharmaceutical properties.
Pepinsky RB; Lee WC; Cornebise M; Gill A; Wortham K; Chen LL; Leone DR; Giza K; Dolinski BM; Perper S; Nickerson-Nutter C; Lepage D; Chakraborty A; Whalley ET; Petter RC; Adams SP; Lobb RR; Scott DM
J Pharmacol Exp Ther; 2005 Feb; 312(2):742-50. PubMed ID: 15485895
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonists.
Gong Y; Barbay JK; Dyatkin AB; Miskowski TA; Kimball ES; Prouty SM; Fisher MC; Santulli RJ; Schneider CR; Wallace NH; Ballentine SA; Hageman WE; Masucci JA; Maryanoff BE; Damiano BP; Andrade-Gordon P; Hlasta DJ; Hornby PJ; He W
J Med Chem; 2006 Jun; 49(11):3402-11. PubMed ID: 16722660
[TBL] [Abstract][Full Text] [Related]
6. CD14 is a ligand for the integrin alpha4beta1.
Humphries JD; Humphries MJ
FEBS Lett; 2007 Feb; 581(4):757-63. PubMed ID: 17274987
[TBL] [Abstract][Full Text] [Related]
7. Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses.
Lin Kc; Ateeq HS; Hsiung SH; Chong LT; Zimmerman CN; Castro A; Lee WC; Hammond CE; Kalkunte S; Chen LL; Pepinsky RB; Leone DR; Sprague AG; Abraham WM; Gill A; Lobb RR; Adams SP
J Med Chem; 1999 Mar; 42(5):920-34. PubMed ID: 10072689
[TBL] [Abstract][Full Text] [Related]
8. Identification of ligand binding sites on integrin alpha4beta1 through chemical cross-linking.
Chen LL; Lobb RR; Cuervo JH; Lin Kc; Adams SP; Pepinsky RB
Biochemistry; 1998 Jun; 37(24):8743-53. PubMed ID: 9628736
[TBL] [Abstract][Full Text] [Related]
9. Comparative assessment of the ligand and metal ion binding properties of integrins alpha9beta1 and alpha4beta1.
Pepinsky RB; Mumford RA; Chen LL; Leone D; Amo SE; Riper GV; Whitty A; Dolinski B; Lobb RR; Dean DC; Chang LL; Raab CE; Si Q; Hagmann WK; Lingham RB
Biochemistry; 2002 Jun; 41(22):7125-41. PubMed ID: 12033947
[TBL] [Abstract][Full Text] [Related]
10. Potent in vivo suppression of inflammation by selectively targeting the high affinity conformation of integrin α4β1.
Vanderslice P; Woodside DG; Caivano AR; Decker ER; Munsch CL; Sherwood SJ; Lejeune WS; Miyamoto YJ; McIntyre BW; Tilton RG; Dixon RA
Biochem Biophys Res Commun; 2010 Oct; 400(4):619-24. PubMed ID: 20807504
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4.
Okigami H; Takeshita K; Tajimi M; Komura H; Albers M; Lehmann TE; Rölle T; Bacon KB
Eur J Pharmacol; 2007 Mar; 559(2-3):202-9. PubMed ID: 17234179
[TBL] [Abstract][Full Text] [Related]
12. Multiple activation states of integrin alpha4beta1 detected through their different affinities for a small molecule ligand.
Chen LL; Whitty A; Lobb RR; Adams SP; Pepinsky RB
J Biol Chem; 1999 May; 274(19):13167-75. PubMed ID: 10224072
[TBL] [Abstract][Full Text] [Related]
13. Adhesion of multiple myeloma peripheral blood B cells to bone marrow fibroblasts: a requirement for CD44 and alpha4beta7.
Masellis-Smith A; Belch AR; Mant MJ; Pilarski LM
Cancer Res; 1997 Mar; 57(5):930-6. PubMed ID: 9041197
[TBL] [Abstract][Full Text] [Related]
14. A label-free approach to identify inhibitors of alpha4beta7-mediated cell adhesion to MadCAM.
Bova MP; Nguyen L; Wallace W; Garrido C; Xu YZ; Semko C; Cockcroft K; Sandberg E; Bard F
J Biomol Screen; 2011 Jun; 16(5):536-44. PubMed ID: 21406619
[TBL] [Abstract][Full Text] [Related]
15. Selective cell adhesion inhibitors: Barbituric acid based alpha4beta7--MAdCAM inhibitors.
Harriman GC; Brewer M; Bennett R; Kuhn C; Bazin M; Larosa G; Skerker P; Cochran N; Gallant D; Baxter D; Picarella D; Jaffee B; Luly JR; Briskin MJ
Bioorg Med Chem Lett; 2008 Apr; 18(7):2509-12. PubMed ID: 18331794
[TBL] [Abstract][Full Text] [Related]
16. Aza-bicyclic amino acid carboxamides as alpha4beta1/alpha4beta7 integrin receptor antagonists.
Dyatkin AB; Gong Y; Miskowski TA; Kimball ES; Prouty SM; Fisher MC; Santulli RJ; Schneider CR; Wallace NH; Hornby PJ; Diamond C; Kinney WA; Maryanoff BE; Damiano BP; He W
Bioorg Med Chem; 2005 Dec; 13(24):6693-702. PubMed ID: 16112583
[TBL] [Abstract][Full Text] [Related]
17. An assessment of the mechanistic differences between two integrin alpha 4 beta 1 inhibitors, the monoclonal antibody TA-2 and the small molecule BIO5192, in rat experimental autoimmune encephalomyelitis.
Leone DR; Giza K; Gill A; Dolinski BM; Yang W; Perper S; Scott DM; Lee WC; Cornebise M; Wortham K; Nickerson-Nutter C; Chen LL; LePage D; Spell JC; Whalley ET; Petter RC; Adams SP; Lobb RR; Pepinsky RB
J Pharmacol Exp Ther; 2003 Jun; 305(3):1150-62. PubMed ID: 12626659
[TBL] [Abstract][Full Text] [Related]
18. Activation pathways of alpha4beta1 integrin leading to distinct T-cell cytoskeleton reorganization, Rac1 regulation and Pyk2 phosphorylation.
Maqueda A; Moyano JV; Gutiérrez-López MD; Ovalle S; Rodríguez-Frade JM; Cabañas C; Garcia-Pardo A
J Cell Physiol; 2006 Jun; 207(3):746-56. PubMed ID: 16514607
[TBL] [Abstract][Full Text] [Related]
19. Rotaviruses interact with alpha4beta7 and alpha4beta1 integrins by binding the same integrin domains as natural ligands.
Graham KL; Fleming FE; Halasz P; Hewish MJ; Nagesha HS; Holmes IH; Takada Y; Coulson BS
J Gen Virol; 2005 Dec; 86(Pt 12):3397-3408. PubMed ID: 16298987
[TBL] [Abstract][Full Text] [Related]
20. A small molecule, orally active, alpha4beta1/alpha4beta7 dual antagonist reduces leukocyte infiltration and airway hyper-responsiveness in an experimental model of allergic asthma in Brown Norway rats.
Cortijo J; Sanz MJ; Iranzo A; Montesinos JL; Nabah YN; Alfón J; Gómez LA; Merlos M; Morcillo EJ
Br J Pharmacol; 2006 Mar; 147(6):661-70. PubMed ID: 16432509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
